2010 milestones: going, going.....?
Eying the calendar, and the closing window of opportunity that is 2010, I'd appreciate some input / opinions on the following:
Given today's date (Dec 8) and the fact that not much happens in late December, what would be the implications of missing the following 2010 milestones:
1) Endo report on the MCC Phase III results.
2) Endo announcement that recruiting has begun for the next MCC clinical study.
Anyone else out there have any particular concerns in this regard? Not that we can do anything about it....
Thanks in advance,
QA
Note: Don't particularly expect to hear from the USDA about Econiche, though it seems long overdue.
After all, having US regulatory approval but no means of supplying the demand (until the vacc plant is ready) is of little practical value. Symbolic value certainly, but that doesn't show up on the top line and won't justify a higher stock price for very long imo.